Sign in
4

Changes in Ownership

Edesa Biotech, Inc. Filed Acc 0001654954-21-004635

Options or other derivatives

  • Chief Financial Officer acquired 80,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

NIFFENEGGER KATHI · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-04-22 Grant or award : show line 1 in the form Stock Option (right to buy) +80,000 80,000 D
Loading xslF345X03/section16.xml…